Recent studies have shown that SLC7A11 is highly expressed in several tumor types, including lung cancer, breast cancer, colorectal cancer, and melanoma, and plays a pivotal role in the immune evasion mechanisms of tumors [24, 25] (Table 1) (Fig. 1). The gene discussed is SLC7A11; the disease is breast carcinoma.